ACP Guidelines Recommend Less-Intensive Treatment Targets for Type 2 Diabetes

The American College of Physicians (ACP) recently issued new guidelines aimed at assisting clinicians in making decisions about targets when using pharmacologic therapy in adults with type 2 diabetes.1Based on evaluation of existing guidelines and clinical studies, the ACP has recommended that clinicians use less intensive treatment target strategies. Studies showed no evidence that lowering HbA1c levels less than 7% provided any additional benefit. The guidelines also suggested de-intensifying treatment for patients with HbA1c levels persistently below 6.5%.

“The evidence shows that for most people with type 2 diabetes, achieving an A1C between 7% and 8% will best balance long-term benefits with harms such as low blood sugar, medication burden, and costs,” said Jack Ende, MD, President, ACP, in a press release.2

Leave a Reply

Your email address will not be published. Required fields are marked *